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Abstract. Annexin VI is one of a family of calcium- 
dependent phospholipid-binding proteins. Although the 
function of this protein is not known, various physio- 
logical roles have been proposed, including a role in 
the budding of clathrin-coated pits (Lin et al., 1992. 
Cell. 70:283-291.). In this study we have investigated 
a possible ndocytotic role for annexin VI in intact 
cells, using the human squamous carcinoma cell line 
A431, and report that these ceils do not express en- 
dogenous annexin VI, as judged by Western and 
Northern blotting and PCR/Southern blotting. To ex- 
amine whether endocytosis might in some way be ei- 
ther facilitated or inhibited by the presence of annexin 
Vt,:a series of A431 clones were isolated in which an- 
nexin VI expression was achieved by stable transfec- 
fion. These cells expressed annexin VI at similar lev- 
els to other human cell types. Using assays for en- 
docytosis and recycling of the transferrin receptor, we 
report that each of these cellular processes occurs with 
identical kinetics in both transfected and wild-type 
A431 cells. In addition, purified, annexin VI failed to 
support he scission of coated pits in permeabilized 
A431 cells. We conclude that annexin VI is not an es- 
sential component of the endocytic pathway, and that 
in A431 cells, almexin VI fails to exert any influence 
on internalization and recycling of the transferrin 
receptor. 
T 
HE annexins are a major class of calcium-binding pro- 
teins, structurally defined by the presence of a con- 
served 70-amino acid domain that occurs as a tetrad 
repeatin most members of the family, but as an octad repeat 
in annexin VI (Crompton et al., 1988a, b). The mammalian 
family includes at least 10 uni.que gene products, several of 
which exist as multiple isoforms that arise as a consequence 
of alternative splicing (Moss and Crumpton, 1990; Mag- 
endzo et al., 1991; Towle et al., 1992). The annexins are 
broadly expressed with representatives of the family present 
in ~/irtually aLl cell types, sometimes constituting more than 
1% of total cell protein. Their conservation fstructure (an- 
nexins typically share ,x,40-50% sequence identity with one 
another) is restricted to the protein core, which in most an- 
nexins comprises almost he entire structure. The repeated 
domains have been shown by both x-ray crystallography and 
mutagenesis, to harbor the Ca2÷-binding sites (Huber et al., 
1990; Jost et al., 1992). 
In contrast, he NH2-terminai domains have little in com- 
mon between annexins and have therefore been suggested to 
confer functional individuality (Crompton et al., 1988b). 
There is good evidence to support his, in that the NH2- 
terminus'of annexin II contains both the binding site for pl 1 
in addition to sites phosphorylated bypp60 v-~ and protein 
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kinase C. The NH2-terminus of annexin I similarly contains 
sites for phosphorylation by the epidermal growth factor 
receptor and protein kinase C. Of all the other annexins, only 
annexins VI and XI are known to be phosphorylated in 
whole cells (Moss et al., 1992; Mizutani et al., 1993), al- 
though the sites of phosphorylatlon are not known. Several 
functions have been proposed for annexin VI, largely based 
on observations from in vitro-derived ata. Like all an- 
nexins, annexin VI is a potent in vitro inhibitor ofphospholi- 
pase A2 (Edwards and Crumpton, 1991), and it also exhibits 
anticoagulant activity (Yoshizald et al., 1992), although both 
phenomena c n be explained by Ca :+ -dependent sequestra- 
tion of phospholipid by. annexin VI, removing the substrate 
in the former case, and the interactive matrix in the latter. 
Other functions attributed to annexin VI include inhibition 
of protein kinase C (Shibata et al., 1992) and modulation of 
the activity of sarcoplasmic reticulum Ca2+-channels (Diaz- 
Munoz et al., 1990). 
Recently.it was reported that annexin VI was required for 
the budding of coated pits from plasma membranes isolated 
from fibroblast~ (Lin et al., 1992). The early stages of 
receptor-mediated endocytosis involve a dynamic series of 
events culminating in the formation of a coated vesicle from 
a deeply invaginated coated pit. Ligands bind to specific 
transmembrane receptors which are either already clustered, 
or become clustered as a result of ligand binding, into coated 
pits. Rearrangement ofthe coat proteins, clathrin a~d adap- 
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tors, results in increased invagination ofthe pit (for reviews 
see Pearse and Robinson, 1990; Smythe and Warren, 1991). 
Scission of the deeply invaginated coated pit to form a coated 
vesicle has an absolute requirement for ATP (Schmid and 
Carter, 1990). Endocytosis in A431 ceils has been exten- 
sively studied both morphologically and biochemically and 
the uptake and recycling of transferrin has been very well- 
characterized (Hopkins and Trowbridge, 1983; Hopkins, 
1985). It has also been possible to use this cell line to recon- 
stitute the early steps of endocytosis, from coated pit forma- 
tion to coated vesicle budding, in a permeabilized cell system 
(Smythe t al., 1989; Schmid and Smythe, 1991). Morpho- 
logical verification of the in vitro assay demonstrated that 
ligand was sequestered into coated pits and internalized into 
coated vesicles which were indistinguishable from those 
seen in intact cells. We now report hat armexin VI is not ex- 
pressed in A431 cells and that in these cells endocytosis must 
therefore occur via a mechanism independent of this protein. 
Materials and Methods 
Cell Culture 
Human A431 squamous carcinoma cells were routinely maintained inDME 
containing 5 % fetal calf serum. 100 U/mi penicillin, and 100/~g/mi strep- 
tomycin. Stock dishes were subcultured to 1:20 at ,'°90% confluence. 
Transfection ofA431 Cells with Annexin VI 
The construct for transfection, amely pRC/CMV.anxVI contained a full- 
length human annexin VI eDNA, created by the ligation of partial ength 
clones A2 and 10.6 (Crompton et al., 1988a). The full-length eDNA was 
directionally cloned into HindIfi/XbaI cut pRC/CMV (Invitrogen Corp., 
U.K.). This vector offers high-level constitutive expression driven by the cy- 
tomegalovirus promoter. On the day before transfection, exponentially 
growing A431 cells were subeultured at '~104 ceUs/em 2 on 90-ram dishes 
and cultured for an additional 24 h. Transfection was achieved using the cal- 
cium phosphate method essentially as described by Graham and Van der 
Eb (1973). Neomycin-resistant colonies were isolated after two weeks and 
examined for expression of annexin VI by Western blotting. Control trans- 
fectants were generated using identical procedures but with wild-type 
vector. 
Immunoblot and Protein Analyses of Annexin II1 
Transfectants 
Wild-type (wt) t A431 ceils and control and annexin VI transfectants were 
routinely cultured as described above. For Western blotting, whole cell ly- 
sates of known cell numbers (refer to Figures for details) were resolved by 
SDS-PAGE (Laemmli, 1970) and transferred to Immobilon-P overnight at 
0.2 A. Annexin VI was detected using a purified IgG fraction of the exten- 
sively characterized rabbit polyelonal antibody MC2 (Crompton et al., 
1988a; Moss et al., 1988; Moss and Crurnpton, 1990; Clark et ai., 1991). 
After incubation i  goat anti-rabbit IgG conjugated toalkaline phosphatase, 
color development was achieved using Western blue (Promega, U.K.). 
Northern Blotting, Southern Blotting, and PCR 
Total cellular RNA was prepared from Jurkat leukemia cells and wild-type 
and transfected A431 cells as described (Chomeyzymski and Saehi, 1987). 
Blots were probed with the A2 human annexin VI eDNA and where indi- 
cated, stripped and reprobed with a glyceraldehyde-3-phosphate de- 
hydrogenase probe as positive control. 
Annexin VI PCR products were generated from cytoplasmic RNA iso- 
lated from Jurkat cells, wtA431 cells, and annexin VI + transfected A431 
cells. The 5' and 3' oligonueleotide primers (5'-TICAACCCTGACGCA- 
1. Abbreviations used in this paper: SFM, serum-free medium; wtA431, 
wild-type A431. 
GAT-3' and 5'-TTCTTGATGGTGTC~TCC-3', respectively) were designed 
to amplify the region between ucleotides 1,186 and 1,840 in the eDNA se- 
quence, and are therefore predicted to yield a fragment of 654 bp. PCR reac- 
tions were performed using Taq DNA polymerase (Promega, U.K.) fol- 
lowing first strand eDNA synthesis using Superscript RNase H- reverse 
transcriptase (GIBCO-BRL, U.K. ) with conditions as recommended by the 
manufacturers. Reaction products were resolved on a 1% (wt/voi) agarose 
gel and visualized by staining in ethidium bromide. Southern blot analysis 
of the PCR products was as described (Maniatis et al., 1982) using the A2 
annexin VI eDNA probe. 
Iodinated Transferrin 
Iodinated transferrin was prepared according to the iodogen method essen- 
tially as described (Woodman and Warren, 1988) except hat 1 mCi of 
Nat25I was used to label 500 tzg of transferrin and the final concentration 
of t251-transferrin was 250 #g/ml. 
Endocytosis Assays 
Internalization Assays. Endocytosis of 125I-transferrin was performed es- 
sentially as described by Hopkins and Trowbridge (1983). Briefly, A431 cell 
lines, grown in 35-mm Coming dishes to 90% eonfluency, were prein- 
eubated with serum-free medium (SFM: DME containing 25 mM Hepes, 
pH 7.4, and 1 mg/rnl BSA) for 30 rain at 37°C. They were then incubated 
with 1251-transferrin (1 pg/ml) in SFM for 90 rain at 4°C. The cells were 
washed three times with dPBS containing 1mg/mi BSA to remove unbound 
ligand. For internalization to occur, the cells were then incubated at 30°C 
for various times in prewarmed SFM containing 10/~g/ml unlabeled trans- 
ferrin. To stop internalization, the cells were chilled on ice and the media 
were removed. Surface 125I-transferrin was stripped by two 10 min washes 
with 0.5 ml acetic acid/saline (0.2 M acetic acid, pH 2.5, 0.5 M NaCl). In- 
ternalized 125I-transferrin was assessed by measuring the radioactivity after 
solubilizing the cells in 1 M NaOH. For each time point, the amount of 
125I-transferrin ternalized was expressed as a percentage of the total 
ligand associated with the cells at zero time. 
Recycling Assays. To measure recycling in A431 cell lines, cells were 
grown to 90% confluency on 35-ram Coming dishes. The cells were loaded 
with 125I-transferrin (4/~g/ml) in SFM for 10 rain at 30°C. After chilling 
on ice, the medium was removed and the surface label removed by mild acid 
washing. The cells were rinsed in 20 mM citrate, pH 5.0, 0.15 M NaCl. They 
were then incubated on ice for 15 rain in 20 mM citrate, pH 5.0, 0.15 M 
NaCl containing 50 ~M desferal (Ciba Laboratories, Horsham, West Sus- 
sex, U.K.). This was followed by a 5-rain incubation in dPBS/BSA. The 
cells were then rewarmed for various times at 30°C in SFM containing I0 
#g/mi unlabeled transfcrrin. The medium was removed and after solubiliza- 
tion of the cells with 1 M NaOH, the amount of cell-associated 12Sl- 
transferrin was measured and expressed as a percentage of that associated 
with cells that were not rewarmed. 
In Vitro Assay of Coated Vesicle Budding. The assay used to measure 
coated vesicle budding was the MesNa resistance assay which was carried 
out as described previously (Smythe t al., 1992; Carter et al., 1993) with 
the modification that the anti-transferrin a tibody used to coat the ELISA 
plates was an IgG fraction prepared from sheep anti-transferrin a tibody. 
This antibody was a generous gift from Scottish Antibody Production Unit 
(Carluke, Scotland). Annexin VI was purified from human placenta s de- 
scribed previously (Edwards and Crumpton, 1990). 
Results 
Lin et al., (1992) have recently reported that annexin VI is 
required for the budding of clathrin-coated pits from isolated 
plasma membranes from sonicated fibroblasts. In this study, 
the aim was to determine whether or not budding of clathrin- 
coated pits required the presence of armexin VI in whole 
cells. Human A431 cells, which have been extensively used 
as a model system for the study of endocytosis were therefore 
examined with respect to expression of annexin VI. 
Annexin VI Is Not Expressed in .4431 Cells 
wtA431 cells were examined for expression of annexin VI by 
Western blotting, Northern blotting, and PCR/Southern 
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Figure 1. Northern blot fannexin VI in A431 and Jurkat cells. Cy- 
toplasmic RNA was isolated from Jurkat ceils and A431 cells and 
probed for armexin VI (Anx II1) by Northern blotting, using the A2 
probe described in Crompton et al., (1988a). The blot was stripped 
and reprobed for GAPDH as an internal control. Lanes 1-4con- 
tained 20, 10, 5, and 1/zg Jurkat RNA respectively and lane 5 con- 
tained 20 #g A431 RNA. 
blotting. With all of these techniques, annexin VI was unde- 
tectable in A431 cells. Annexin VI mRNA could be readily 
detected inJurkat cells (Fig. 1, lanes 1-4) even using as little 
as 1 #g total RNA, whereas in A431 cells, no signal was ob- 
served with 20 #g RNA (Fig. 1, lane 5). Reprobing of the 
stripped blot with GAPDH testified to the integrity of all the 
samples. Analysis of A431 cell RNA by PCR using annexin 
VI-specific primers imilarly failed to yield a clear product 
(Fig. 2 A, lane 2), whereas RNA from both Jurkat cells and 
A431 cells stably transfected with annexin VI (Fig. 2 A, 
lanes 1 and 3) both yielded a single product of the correct 
predicted size. To further confirm that this product was in- 
deed armexin VI in derivation, the same gel was Southern 
blotted and probed with the A2 annexin VI cDNA. Bands 
corresponding to the PCR products from the Jurkat cells and 
the transfected A431 cells (Fig. 2 B, lanes 1 and 3) both gave 
a positive signal, whereas no signal was observed in the 
wtA431 cells (Fig. 2 B, lane 2). 
Stable Expression of Annexin VI in ,4431 Cells 
Following transfection ofA431 cells with pRC/CMV.anxVI, 
a series of stable neomycin-resistant li es was isolated and 
cultured for several months with constant monitoring for ex- 
pression of annexin VI (judged by Western blotting). For the 
purposes of these experiments, two expressing clones (C3 
and CK), one nonexpressing clone (C7), and wtA431 cells 
were selected. Full analyses of armexin VI expression levels 
and growth characteristics of these clones will be reported 
elsewhere (Theobald, J., E D. Smith, S. M. Jacob, and S. E. 
Moss, manuscript inpreparation). A representative W stern 
blot is shown in Fig. 3, illustrating annexin VI in a whole cell 
lysate of C3 but undetectable in wtA431. These results, to- 
gether with the Northern blotting and PCR/Southern blot- 
ring data, provide convincing evidence that annexin VI is not 
expressed in wtA431 cells. 
Endocytosis of Transferrin Receptors in wtA431 
and Transfectants 
Endocytosis and Recycling of Transferrin Receptors in 
wtA431 Cells and Transfectants. The results of Lin et al. 
(1992) suggest that annexin VI has a role in coated-vesicle 
budding. Since A431 cells do not normally express annexin 
VI, it was of interest to examine whether the presence of an- 
nexin VI in these cells affected the rates of endocytosis. The 
internalization kinetics of 12~I-transferrin were examined in 
Figure 2. PCR analysis of annexin VI in A431, C3, and Jurkat cells. 
(A) Annexin VI PCR products were generated from cytoplasmic 
RNA isolated from Jurkat cells (lane/), A431 cells (lane 2), and 
C3 (A431 cells transfected with armexin VI) (lane 3). DNA size 
markers are shown in lane 4. The 5' and 3' oligonucleotide primers 
were designed to amplify the region between nucleotides 1,186 and 
1,840 in the eDNA sequence, and are therefore predicted to yield 
a fragment of~654 bp. PCR products were visualized by ethidium 
bromide staining and photographed under UV light. (B) Southern 
blot of the same gel using a random-primed probe derived from 
nucleotides 1,260-1,600 in the human annexin VI eDNA. Bands of 
the correct predicted size are observed in lanes 1 and 3.
wtA431 cells and in the transfected cell lines. Fig. 4 shows 
that all the cell lines tested show essentially the same rates 
and extent of internalization. We next examined the rates of 
recycling in both wild-type and transfected cells. Fig. 5 
shows that the rates of recycling are unchanged in the trans- 
fected cells. 
Annexin I11 Does Not Support Coated Vesicle Budding 
in Permeabilized.4431 Cells. The formation of coated vesi- 
cles in permeabilized A431 cells has been reconstituted 
(Schmid and Smythe, 1991). In order to measure budding, 
transferrin which has been biotinylated via a cleavable disul- 
phide linkage (BSST) is used as a reporter molecule. The ac- 
quisition of BSST resistance to the small reducing agent, 
MesNa, provides a measure of transferrin internalization 
into bona fide coated vesicles. Morphological studies con- 
firmed that BSST was being internalized into coated vesicles 
identical to those found in intact cells (Smythe t al., 1989; 
Schmid and Smythe, 1991). Scission of deeply invaginated 
coated pits to form coated vesicles requires both cytosol 
and ATE 
We investigated the possibility that annexin VI might 
fulfill some or all of the cytosolic requirement for this event. 
Titration of annexin VI over a range of concentrations from 
12.5-100/zg/ml revealed that purified armexin VI is unable 
to stimulate coated vesicle budding in permeabilized A431 
cells either in the absence or presence of low levels of cytosol 
(Fig. 6 a). Treatment of bovine brain cytosol with 10 mM 
calcium results in the formation of aggregates of annexins 
which may be separated from cytosol by centrifugation. 
Studies by Lin et al., (1992) showed that cytosol treated in 
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Figure 5. Recycling of t25I-transferrin in wild-type and transfected 
A431 cells. Wild-type and transfected A431 ceils (wt, C3, C7, CK) 
were loaded with t25I-transferrin for 10 rain at 30°C. Cell-surface 
ligand was removed at 0°C using conditions of mild acid stripping 
as described in Materials and Methods. The cells were then re- 
warmed at 30°C for various times and theamount of cell-associated 
t25I-transferrin determined after solubllizing the cells in 1 M 
NaOH. Valuesare expressed as the mean of three separate experi- 
ments, +SEM, each performed in duplicate. 
Figure 3. Western blot of armexin VI in C3 and wtA431 cells. Sam- 
ples of whole cell lysates containing •5 x 106 ceils were sepa- 
rated by SDS-PAGE and transferred to Imm0bilon-P. The first anti- 
body was a polyclonal rabbit anti-(armexin VI) serum and the 
second was a goat an i-(rabbit IgG)-alkaline phosphatase conju- 
gate. Color development was achieved using Western blue. La e 1, 
C3. Lane 2, wtA431. The positions of annexin VI (Anx VI) and mo- 
lecular weight markers are indicated. 
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Figure 4. Endocytosis of t2~I-transferrin in wild-type and trans- 
fected A431 cells. ~25I-Transferrin (1 /~g/ml) was bound at 4"C to 
the cell surface of near confluent A431 cell lines (wt, annexin VI 
transfected clones, C3 and CK, and mock-transfected clone C7). 
Following removal of unbound ligand, the ceils were warmed at 
30°C for various times. After chilling on ice, surface ~z~I-trans- 
ferrin was removed byacid stripping as described in Materials and 
Methods. The amount of internalized t25I-transferrin was deter- 
mined after solubilization of the cells using 1 M NaOH. Values are 
expressed as the mean of three separate experiments, 5=SEM, each 
performed in duplicate. 
this manner was reduced in its ability to stimulate clathrin 
loss from isolated fibroblast plasma membranes. Similarly 
we also observed that dalcium-treated cytosol shows a loss 
in ability to support coated-vesicle budding in permeabilized 
A431 cells. Bovine brain cytosol (10 mg/ml) was treated with 
10 mM CaCI2 on ice for 15 min and then centrifuged at 
100,000 g for 1 h. The supernatant was dialyzed extensively 
against assay buffer and then assayed for coated-vesicle bud- 
ding activity (Figure 6 b), The depleted cytosol shows re- 
duced activity in the assay. Purified annexin VI, added back 
at protein concentrations corresponding to 1% of the cyto- 
solic protein, was unable to restore activity to the calcium- 
treated cytosol. 
Efforts to reconstitute activity from the pellet obtained af- 
ter calcium treatment were unsuccessful (data not shown), 
suggesting that some component essential for budding had 
been irreversibly precipitated/inactivated. SDS-PAGE and 
Western blotting analysis of the pellet and supernatant after 
centrifugation revealed that, in addition to precipitation of 
>195 % of annexin VI, calcium precipitation resulted in 
precipitation of a number of other proteins (data not shown). 
These proteins may be essential components of the scission 
machinery. Therefore, we conclude from these results that 
annexin VI has no apparent role in the budding of coated 
vesicles in permeabilized A431 cells. 
Discussion 
Members of the annexin family have been attributed with a 
variety of proposed functions including phospholipase A2 
inhibition (Russo-Marie, 1992), inhibition of blood coagula- 
tion (Yoshizaki et al., 1992), exocytosis (Creutz, 1992), 
CaZ+-channel activity (Huber et al., 1990), inositol phos- 
phate metabolism (Ross et al., 1990), and most recently, 
steps in the endocytic pathway including budding of clathrin- 
coated pits (Lin et al., 1992), endosome fusion (Emans et 
al., 1993), and lysosomal targetting (Futter et al., 1993). It 
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Figure 6. Coated-vesicle budding in permeabilized A431 ceils oc- 
curs independently of armexin VI. (A) Purified armexin VI (12.5- 
100/zg/ml final concentration) was added to permeabilized A431 
ceils in the presence or absence of low levels of cytosol (1.25 mg/ 
ml). The extent of coated vesicle budding was assayed using the 
MesNa resistance assay as described in the Materials and Methods. 
The asterisk indicates hemaximum extent of coated vesicle bud- 
ding under conditions of saturating cytosol observed in this experi- 
ment. (B) Cytosol was treated with 10 mM CaCI2, centrifuged at 
100,000 g, and dialyzed extensively to remove Ca r. It was then 
assayed for its ability to support coated-vesicle budding as mea- 
sured by the MesNa resistance assay compared with mock-treated 
cytosol. Purified annexin VI was added back tothe calcium-treated 
cytosol at concentrations corresponding t  1% of the cytosolic pro- 
tein in each case. 
is interesting to note that individual annexins are now sug- 
gested to function in both endocytic and exocytic pathways. 
We have shown here by a variety of techniques that human 
A431 squamous carcinoma cells do not express annexin VI. 
The protein was undetectable byWestern blotting, and the 
mRNA was undetectable by either Northern blotting or 
PCR/Southern blotting. Positive controls in each case testi- 
fied to the efficacy of the techniques. A431 cells have been 
extensively used in numerous laboratories for the study of 
endocytosis and the budding of clathrin-coated pits. Using 
an assay for the internalization of transferrin, which is 
known to occur via the budding of clathrin-coated pits in 
these cells, we have demonstrated that A431 cells effectively 
perform this function without a requirement for annexin VI. 
Furthermore, stable expression of annexin VI in these ceils 
had no effect on the endocytosis oftransferrin receptors. Our 
results clearly challenge the conclusions of Lin et al. (1992), 
who reported that annexin VI is required for the budding of 
clathrin-coated pits. How may one account for this apparent 
discrepancy? 
One possible xplanation is functional redundancy within 
the annexin family. There are precedents for this, exem- 
plified by the observations that annexins exhibit similar ac- 
tivities as both anticoagulants and phospholipase A2 inhibi- 
tors in vitro. However, this is unlikely in this case since 
Lin et al. (1992) demonstrated that budding was stimulated 
specifically by annexin VI, although not all annexins were 
tested. In addition, the detection methods used in this study, 
Western blotting, NOrthern blotting, and PCR/Southern 
blotting, collectively fiiled to  detect any other protein in 
A431 cells, the implication being that if A431 cells express 
a functional homolog, then it is unlikely to be structurally 
related to annexin VI. A second more plausible ~ xplanation 
is that annexin VI, like other members of the.family, iscapa- 
ble of multiple functions in vitro, and that he cell-free assay 
conditions of Lin et al. (1992) invoke'~rlUSU~iprope~es in 
annexin VI. A third possibility is that annexin VI forms part 
of the budding machinery in certain cell' types but not in 
others. This argument precludes amaexin VI from part of a 
universal mechanism of endocytosis and this would be sur- 
prising given the high degree of conservation of the compo- 
nents of the endocytic pathway throughout eukaryotic evo- 
lution. 
Stable transfection of annexin VI in A431 cells had no 
effect on the endocytosis of transferrin receptors. An effect 
on the kinetics of endocytosis might only be observed after 
transfection if the protein was rate limiting on the endocytic 
pathway. The small GTP-binding proteins rab4 and rab5 ap- 
pear to be rate limiting on the early endocytic pathway and 
cells where they are overexpressed show altered rates of re- 
cycling and internalization, respectiyely (Bucci et al., 1992; 
van der Sluijs et al., 1992). In contrast, although rab2 is in- 
volved in transport from the ER to the Golgi complex, over- 
expression ofthe protein does not accelerate the rate of trans- 
port at this step (Tisdale et al., 1992). However, since 
annexin VI is normally absent from A431 cells, one would 
pr dict hat its presence would affect he rates and extent of 
inte n lization if it were an essential component of the bud- 
cling machinery. 
In addition, we were unable to detect a role for purified 
annexin VI in an assay for coated-vesicle budding in permea- 
bilized A431 cells. Annexin VI, either alone or in the pres- 
ence of cytosol, was unable to support coated vesicle bud- 
ding in permeabilized A431 cells. Depletion of annexin VI 
and other components from cytosol by precipitation with 
calcium resulted in a reduced ability of the cytosol to support 
coated vesicle budding but this loss in activity could not be 
rescued by addition of purified annexin VI, suggesting that 
some other essential component(s) was removed/inactivated 
by this treatment. Although it is possible that he purified an- 
nexin VI had lost some essential but uncharacterized activity 
during its preparation, this is unlikely given that there was 
no evidence ofproteolysis or loss of ability to bind calcium 
dependently to phospholipids (results not shown). These 
data, in combination with the results using the transfected 
cells, lead us to conclude that annexin VI is not essential for 
the budding of clathrin-coated pits, since A431 cells lack an- 
nexin VI yet perform this function. 
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